Pig Interleukin 6 (IL6) Protein
338€ (5 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Pig Interleukin 6 (IL6) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx670315
tested applications
ELISA, WB
Description
Pig Interleukin 6 (IL6) Protein is a Recombinant protein expressed in Pichia pastoris.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Proteins and Peptides |
| Immunogen Target | Interleukin 6 (IL6) |
| Host | Yeast |
| Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
| Origin | Pig |
| Conjugation | Unconjugated |
| Size 1 | 5 µg |
| Form | Lyophilized |
| Tested Applications | ELISA, WB |
| Buffer | Prior to lyophilization: Phosphate buffered saline |
| Availability | Shipped within 3-7 working days. |
| Storage | Store at 4 °C for up to one week. For long-term storage, store at -20 °C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | P26893 |
| Alias | IL-6,BSF,HGF,HSF,IFNB2,CDF,B-cell stimulatory factor 2 |
| Background | Protein IL6 |
| Status | RUO |
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
IL6 is a pleiotropic cytokine involved in regulating immune responses, inflammation, and hematopoiesis It is produced by macrophages, T cells, fibroblasts, and endothelial cells in response to infections, trauma, or tissue damage IL6 activates downstream signaling through its receptor, IL-6R, and the JAK/STAT3 pathway, driving acute-phase protein synthesis, such as CRP and fibrinogen, and promoting B cell differentiation into plasma cells Dysregulated IL6 expression is associated with chronic inflammation, autoimmune diseases like rheumatoid arthritis, and cancer progression, where it promotes tumor growth, survival, and angiogenesis IL6 also contributes to cytokine storm syndrome in conditions like COVID-19, where excessive IL6 leads to hyperinflammation and organ damage Targeting IL6 signaling with anti-IL6 therapies, such as tocilizumab, has shown efficacy in treating autoimmune diseases and cytokine-driven conditions
Related Products
APC Anti-Human IL-6(MQ2-13A5)
Ver Producto
Human HS-IL-6 (High sensitive Interleukin 6) high sensitive Accquant ELISA Kit
Ver Producto